The DOI matches its Crossref record; 62 of the 64 references it cites were found in a registry or an index.
The Metabolic Profile of Tumors Depends on Both the Responsible Genetic Lesion and Tissue Type
Open accessAbstract
The altered metabolism of tumors has been considered a target for anticancer therapy. However, the relationship between distinct tumor-initiating lesions and anomalies of tumor metabolism in vivo has not been addressed. We report that MYC-induced mouse liver tumors significantly increase both glucose and glutamine catabolism, whereas MET-induced liver tumors use glucose to produce glutamine. Increased glutamine catabolism in MYC-induced liver tumors is associated with decreased levels of glutamine synthetase (Glul) and the switch from Gls2 to Gls1 glutaminase. In contrast to liver tumors, MYC-induced lung tumors display increased expression of both Glul and Gls1 and accumulate glutamine. We also show that inhibition of Gls1 kills cells that overexpress MYC and catabolize glutamine. Our results suggest that the metabolic profiles of tumors are likely to depend on both the genotype and tissue of origin and have implications regarding the design of therapies targeting tumor metabolism.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Importantly, inhibiting glutamine entry into the TCA cycle can blunt tumor progression in a MYC-driven cancer model of liver cancer (Xiang et al., 2015; Yuneva et al., 2012) and a MYC-inducible Burkitt lymphoma model (Le et al., 2012; Xiang et al., 2015).”
From Targeting Metabolism for Cancer Therapy (2017) · cites this paper as Yuneva et al., 2012
In the citing paper
“MYC has been found to increase mRNA and protein levels of glutamine transporters as well as expression of the enzyme glutaminase, which catalyzes the first step in glutaminolysis (Gao et al., 2009; Wise et al., 2008; Yuneva et al., 2012).”
From Targeting Metabolism for Cancer Therapy (2017) · cites this paper as Yuneva et al., 2012
In the citing paper
“Second, although different oncogenes reprogram metabolism in different ways, the tissue in which the oncogene is expressed affects the execution of metabolic reprogramming.”
From Metabolic reprogramming and cancer progression (2020) · cites this paper as [5]
In the citing paper
“Transgenic MYC induces metabolic changes in both liver tumors and lung tumors but activates glutamine catabolism in lung tumors and glutamine synthesis in liver tumors.”
From Metabolic reprogramming and cancer progression (2020) · cites this paper as [5]
In the citing paper
“MYC-driven cancer cells exhibit enhanced glutamine utilization accompanied by increased expression of key glutaminolysis enzymes, including GLS1/GLS2 and GLUD1178–180.”
From Glutamine reliance in cell metabolism (2020) · cites this paper as [179]
In the citing paper
“For example, liver tumors with aberrant overexpression of MYC display enhanced glutamine oxidation and sensitivity to therapies that target glutamine catabolism relative to liver tumors driven by overexpression of MET (196).”
From Regulation and function of the mammalian tricarboxylic acid cycle (2023) · cites this paper as [196]
In the citing paper
“furthermore, a similar accumulation of glucose-derived glutamine within the tumor tissue was observed in a mouse model of c-Met-driven liver cancer (Yuneva et al., 2012).”
From The emerging hallmarks of cancer metabolism (2016) · cites this paper as Yuneva et al., 2012
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Warburg, O. (1956) · Science · doi:10.1126/science.123.3191.309 · Cited by 13,425
Why Do Cancers Have High Aerobic Glycolysis?
Gatenby, R. A., & Gillies, R. J. (2004) · Nature reviews. Cancer · doi:10.1038/nrc1478 · Cited by 4,784
Cancer genes and the pathways they control
Vogelstein, B., & Kinzler, K. W. (2004) · Nature Medicine · doi:10.1038/nm1087 · Cited by 4,346
The Biology of Cancer: Metabolic Reprogramming Fuels Cell Growth and Proliferation
DeBerardinis, R. J., Lum, J. J., Hatzivassiliou, G., & Thompson, C. B. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2007.10.002 · Cited by 4,088
Gao, P., Tchernyshyov, I., Chang, T.-C., Lee, Y.-S., Kita, K., Ochi, T., Zeller, K. I., De Marzo, A. M., Van Eyk, J. E., Mendell, J. T., et al. (2009) · Nature · doi:10.1038/nature07823 · Cited by 2,124
Wise, D. R., DeBerardinis, R. J., Mancuso, A., Sayed, N., Zhang, X.-Y., Pfeiffer, H. K., Nissim, I., Daikhin, E., Yudkoff, M., McMahon, S. B., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0810199105 · Cited by 2,001
Bidirectional Transport of Amino Acids Regulates mTOR and Autophagy
Nicklin, P., Bergman, P., Zhang, B., Triantafellow, E., Wang, H., Nyfeler, B., Yang, H., Hild, M., Kung, C., Wilson, C., et al. (2009) · Cell · doi:10.1016/j.cell.2008.11.044 · Cited by 1,798
Wnt signalling and its impact on development and cancer
Klaus, A., & Birchmeier, W. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2389 · Cited by 1,595
Reflecting on 25 years with MYC
Meyer, N., & Penn, L. Z. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2231 · Cited by 1,575
Molecular pathogenesis of human hepatocellular carcinoma
Thorgeirsson, S. S., & Grisham, J. W. (2002) · Nature Genetics · doi:10.1038/ng0802-339 · Cited by 1,456
Flagged first, then by citations
2 of the 64 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Items 501–600 of 638
Genetic buffering and potentiation in metabolism
Poyatos, J. F. (2020) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1008185 · Cited by 7
Systematic Identification of MACC1-Driven Metabolic Networks in Colorectal Cancer
Lisec, J., Kobelt, D., Walther, W., Mokrizkij, M., Grötzinger, C., Jaeger, C., Baum, K., Simon, M., Wolf, J., Beindorff, N., et al. (2021) · Cancers · doi:10.3390/cancers13050978 · Cited by 7
Unique Metabolic Contexts Sensitize Cancer Cells and Discriminate between Glycolytic Tumor Types
Chacon-Barahona, J. A., MacKeigan, J. P., & Lanning, N. J. (2023) · Cancers · doi:10.3390/cancers15041158 · Cited by 7
NF-YA overexpression protects from glutamine deprivation
Dolfini, D., Minuzzo, M., Sertic, S., & Mantovani, R. (2019) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2019.118571 · Cited by 7
Hamad, A. B., Zhang, H., Zhang, Y., Shen, C., Fa, P., Huang, H., Ejaz, A. M., & Tsung, A. (2025) · BMC Sports Science Medicine and Rehabilitation · doi:10.1186/s13102-025-01094-6 · Cited by 7
LOX-1 rewires glutamine ammonia metabolism to drive liver fibrosis
Huang, R., Cui, H., Alshami, M. A. Y. A., Fu, C., Jiang, W. H., Cai, M., Zhou, S., Zhu, X., & Hu, C. (2025) · Molecular Metabolism · doi:10.1016/j.molmet.2025.102132 · Cited by 6
Seo, Y., Craig, M. C., Murphy, S. T., Feng, J., Chen, X., & Yuneva, M. O. (2022) · Molecular Imaging · doi:10.1155/2022/5185951 · Cited by 6
Self-citationLysine‐372‐dependent SUMOylation inhibits the enzymatic activity of glutamine synthases
Ling, T., Li, S., Chen, H., Wang, Q., Shi, J., Li, Y., Bao, W., Liang, K., & Piao, H. (2023) · The FASEB Journal · doi:10.1096/fj.202301462rr · Cited by 7
Zhang, Y., Xie, L., Fujinaga, M., Kurihara, Y., Ogawa, M., Kumata, K., Mori, W., Kokufuta, T., Nengaki, N., Wakizaka, H., et al. (2024) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2024.07.023 · Cited by 6
Venkateswaran, S. V., Kreuzaler, P. A., Maclachlan, C., McMahon, G., Greenidge, G., Collinson, L., Bunch, J., & Yuneva, M. O. (2025) · Nature Protocols · doi:10.1038/s41596-024-01118-4 · Cited by 6
Self-citationHexokinases in gastrointestinal cancers: From molecular insights to therapeutic opportunities
Liang, G., Ma, Y., Deng, P., Li, S., He, C., He, H., Liu, H., Fan, Y., & Li, Z. (2025) · Seminars in Oncology · doi:10.1016/j.seminoncol.2025.152351 · Cited by 6
Balancing redox stress: anchorage-independent growth requires reductive carboxylation
Stalnecker, C. A., Cluntun, A. A., & Cerione, R. A. (2016) · Translational Cancer Research · doi:10.21037/tcr.2016.09.02 · Cited by 6
Physiopathologie de la dénutrition
Cynober, L. (2014) · Revue Francophone des Laboratoires · doi:10.1016/s1773-035x(14)72643-7 · Cited by 6
Chemokine clouding and liver cancer heterogeneity: Does it impact clinical outcomes?
Ahmad, M., Dhasmana, A., Harne, P. S., Zamir, A., & Hafeez, B. B. (2022) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2022.02.015 · Cited by 6
Ghasemishahrestani, Z., Mattos, L. M. M., Tilli, T. M., dos Santos, A. L. S., & Pereira, M. D. (2020) · Current Medicinal Chemistry · doi:10.2174/0929867327999200819123357 · Cited by 6
Glutamine metabolism, the Achilles heel for medulloblastoma tumor
Niklison-Chirou, M. V. (2018) · Cell Death and Disease · doi:10.1038/s41419-017-0117-1 · Cited by 6
Ding, R., Zhou, Y., Zhang, Q., Kong, X., Li, Q., Zhang, S., Chen, Y., An, X., & Li, Z. (2024) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2024.1507102 · Cited by 5
Wang, X., Wang, Z., Liu, Z., Huang, F., Pan, Z., Zhang, Z., & Liu, T. (2025) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2025.189322 · Cited by 5
Bayesian kinetic modeling for tracer-based metabolomic data
Zhang, X., Su, Y., Lane, A. N., Stromberg, A. J., Fan, T. W. ‐., & Wang, C. (2023) · BMC Bioinformatics · doi:10.1186/s12859-023-05211-5 · Cited by 5
Self-citationMetabolic Heterogeneity of Tumors
Shirmanova, M. V., Sinyushkina, S. D., & Komarova, A. D. (2023) · Molecular Biology · doi:10.1134/s002689332306016x · Cited by 5
Plasma metabolomics reveals risk factors for lung adenocarcinoma
Yu, M., Wen, W., Wang, Y., Xia, S., Yi, X., Zhu, W., Aa, J., & Wang, G. (2024) · Frontiers in Oncology · doi:10.3389/fonc.2024.1277206 · Cited by 5
In search for symmetries in the metabolism of cancer
Gatto, F., & Nielsen, J. (2015) · WIREs Systems Biology and Medicine · doi:10.1002/wsbm.1321 · Cited by 5
Jéney, A., Hujber, Z., Szoboszlai, N., Fullár, A., Oláh, J., Pap, É., Márk, Á., Kriston, C., Kralovánszky, J., Kovalszky, I., et al. (2016) · Cancer Cell International · doi:10.1186/s12935-016-0281-x · Cited by 5
A novel role for the extended MYC network in cancer cell survival
Carroll, P. A., & Diolaiti, D. (2015) · Molecular & Cellular Oncology · doi:10.1080/23723556.2015.1026528 · Cited by 5
Analyzing the Metabolism of Metastases in Mice
Altea‐Manzano, P., Broekaert, D., Duarte, J. A. G., Fernández-García, J., Planque, M., & Fendt, S. (2019) · Methods in molecular biology · doi:10.1007/978-1-0716-0159-4_6 · Cited by 5
Nrf2 Mutation/Activation Is Dispensable for the Development of Chemically Induced Mouse HCC
Mattu, S., Zavattari, P., Kowalik, M. A., Serra, M., Sulas, P., Pal, R. R., Puliga, E., Sutti, S., Foglia, B., Parola, M., et al. (2021) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2021.08.011 · Cited by 5
He, Z., Gao, Y., Li, T., Yu, C., Ou, L., & Luo, C. (2022) · International Journal of Oncology · doi:10.3892/ijo.2022.5327 · Cited by 5
Metabolic cancer therapy: proof of concept
Chubenko, V. A., & Moiseyenko, V. М. (2022) · doi:10.31917/2301051 · Cited by 5
RAS: Circuitry and therapeutic targeting
Singh, G., Thakur, N., & Kumar, U. (2022) · Cellular Signalling · doi:10.1016/j.cellsig.2022.110505 · Cited by 6
Avantaggiati, M. L. (2013) · PubMed · Cited by 5
13C Flux Analysis in Biotechnology and Medicine
Cheah, Y. E., Hasenour, C. M., & Young, J. D. (2017) · Systems Biology · doi:10.1002/9783527696130.ch2 · Cited by 5
Galluzzi, L., & Kroemer, G. (2014) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/b978-0-12-416618-9.10000-7 · Cited by 5
Cancer Metabolism Historical Perspectives: A Chronicle of Controversies and ConsensusPreprint
Dang, C. V. (2023) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a041530 · Cited by 5
p53: An Immune Ecosystem Manipulator
Nian, Z., Dou, Y., & Wei, H. (2025) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-24-3628 · Cited by 4
Ni, C. S., & Li, J. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e22814 · Cited by 4
Li, X., Li, D., Li, J., Chen, Y., Cai, Z., & Tan, F. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241411753 · Cited by 4
Genomic and metabolomic analysis of step-wise malignant transformation in human skin fibroblasts
Kariagina, A., Lunt, S. Y., & McCormick, J. J. (2019) · Carcinogenesis · doi:10.1093/carcin/bgz126 · Cited by 4
Challenging Roadblocks to Cancer Cure
Loda, M. F. (2016) · Cancer Research · doi:10.1158/0008-5472.can-16-1443 · Cited by 4
Maali, A., Sarfi, M., Mirzakhani, M., Goodarzi, G., Maghsoudi, H., Maniati, M., Tehrani, S. S., & Qujeq, D. (2020) · Current Chemical Biology · doi:10.2174/2212796814999200925162943 · Cited by 4
Galluzzi, L., & Kroemer, G. (2014) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/b978-0-12-801329-8.10000-5 · Cited by 4
Q-ing tumor glutaminase therapy
Stine, Z. E., & Dang, C. V. (2015) · Oncotarget · doi:10.18632/oncotarget.6301 · Cited by 4
Metabolic permissiveness: how tissue context shapes cancerPreprint
Moschandrea, C., & Frezza, C. (2026) · Genes & Development · doi:10.1101/gad.353516.125 · Cited by 4
Kong, D., Zhou, Q., He, K., Heegsma, J., Blokzijl, H., de Meijer, V. E., & Faber, K. N. (2025) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-025-05772-z · Cited by 3
The Mammary Tumor Microenvironment
Curran, C. S., & Ponik, S. M. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-59038-3_10 · Cited by 3
Metabolic pathway analysis of tumors using stable isotopes
Bi, Q., Zhao, J., Nie, J. H., & Huang, F. (2025) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2025.05.002 · Cited by 3
Balancing the cellular budget: Lessons in metabolism from microbes to cancer
Vibishan, B., Jolly, M. K., & Goyal, A. (2025) · Biosystems · doi:10.1016/j.biosystems.2025.105571 · Cited by 3
p73 keeps metabolic control in the family
Fets, L., & Anastasiou, D. (2013) · Nature Cell Biology · doi:10.1038/ncb2810 · Cited by 3
Zhang, Y., Zhang, X., Lane, A. N., Fan, T. W. ‐., & Liu, J. (2018) · ACM International Conference on Bioinformatics, Computational Biology, and Health Informatics (ACM-BCB) · doi:10.1145/3233547.3233580 · Cited by 3
Self-citationMetabolic Reprogramming and Molecular Rewiring in Cancer: Therapeutic Opportunities
Meiliana, A., Dewi, N. M., & Wijaya, A. (2021) · The Indonesian Biomedical Journal · doi:10.18585/inabj.v13i2.1598 · Cited by 3
Distinct Essentiality of the Mitochondrial Respiratory Chain in Proliferating Cells In Vivo
Bosc, C., & Chandel, N. S. (2024) · Annual Review of Cancer Biology · doi:10.1146/annurev-cancerbio-061424-125611 · Cited by 3
Recent progress of amino acid transporters as a novel antitumor target
Zhao, J.-Y., Lv, J., Chen, Y., Dong, Q., & Dong, H.-R. (2022) · Open Chemistry · doi:10.1515/chem-2022-0239 · Cited by 2
Garcia, B. M., & Altea‐Manzano, P. (2025) · Cancer Research · doi:10.1158/0008-5472.can-25-5633 · Cited by 2
Darunavir analog precursors target mitochondrial metabolism in multiple myeloma and CLL.
Mecca, M., Sichetti, M., Spina, E. L., Giuseffi, M., Giglio, E., Picerno, S., Valvano, L., Statuto, T., Santarsiere, A., Funicello, M., et al. (2025) · Cancer Cell International · doi:10.1186/s12935-025-04142-w · Cited by 2
Chen, S., Fu, X., Zhang, T., Zhou, R., Liu, L., Zeng, L., Xu, B., Zhu, H., & Li, Z. (2026) · Cell Death and Disease · doi:10.1038/s41419-026-08573-9 · Cited by 2
El-Helbawy, N. F., & Zowalaty, A. E. E. (2022) · Current Issues in Molecular Biology · doi:10.3390/cimb44090282 · Cited by 2
Metabolite Changes Associated with Resectable Pancreatic Ductal Adenocarcinoma
McDonnell, D., Afolabi, P. R., Niazi, U. H. K., Wilding, S. A., Griffiths, G. O., Swann, J. R., Byrne, C. D., & Hamady, Z. Z. R. (2025) · Cancers · doi:10.3390/cancers17071150 · Cited by 2
Cancer Metabolism: A Nexus of Matter, Energy, and Reactive Oxygen Species
Bingham, P. M., Stuart, S. D., & Zachar, Z. (2014) · Cancer drug discovery and develogment/Cancer drug discovery and development · doi:10.1007/978-1-4614-9545-1_2 · Cited by 2
Tumor Metabolism: Challenges and Future Perspectives
da Silva, E. L., Montenegro, R. C., & Moreira-Nunes, C. A. (2023) · Springer eBooks · doi:10.1007/978-3-030-80962-1_103-1 · Cited by 3
Mechanism of Tumor Growth and Metastasis
Dias, F. C. R., Oliveira, J. B., Pinheiro, B. S. S., Pacheco, H. F. M., Rodrigues, J. G., Fernandes, J. L. F., & Gomes, M. D. L. M. (2024) · Interdisciplinary cancer research · doi:10.1007/16833_2024_406 · Cited by 2
Metabolic checkpoints in glioblastomas: targets for new therapies and non-invasive detection
Li, W., Wang, Z., Chen, S., Zuo, M., Xiang, Y., Yuan, Y., He, Y., Zhang, S., & Liu, Y. (2024) · Frontiers in Oncology · doi:10.3389/fonc.2024.1462424 · Cited by 2
Choucair, K., Elliott, A., Oberley, M. J., Walker, P., Salama, A. K. S., Saeed, A., Mamdani, H. M., Uprety, D., El‐Deiry, W. S., Beltran, H., et al. (2025) · BMJ Oncology · doi:10.1136/bmjonc-2024-000551 · Cited by 2
Poulogiannis, G. (2017) · Methods in molecular biology · doi:10.1007/978-1-4939-7154-1_26 · Cited by 2
T cells critically depend on pyruvate oxidation
Schrecker, C., & Intlekofer, A. M. (2021) · Cell Metabolism · doi:10.1016/j.cmet.2021.08.010 · Cited by 2
Karimpur-zahmatkesh, A., Khalaj‐Kondori, M., Feizi, M. A. H., & Baradaran, B. (2023) · EXCLI journal · doi:10.17179/excli2023-6287 · Cited by 2
MYC Regulation of Metabolism and Cancer
Gouw, A. M., Hsieh, A. L., Stine, Z. E., & Dang, C. V. (2015) · Springer eBooks · doi:10.1007/978-3-7091-1824-5_5 · Cited by 2
Metabolic dysregulation in cancer progression
Arfin, S., Agrawal, K., Kumar, A., Kumar, A. J., Rathi, B., & Kumar, D. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-99879-6.00008-0 · Cited by 2
mTOR signaling in liver disease
Cornu, M., de Coquereaumont, G. D. C., & Hall, M. N. (2015) · Wiley eBooks · doi:10.1002/9781118663387.ch22 · Cited by 2
Vousden, K. H., & Yang, M. H. (2016) · Science · doi:10.1126/science.aai7629 · Cited by 2
Molecular Targets for Cancer Immunotherapy: Focusing on (Immune and Tumor) Cell-Derived Metabolites
Quintans, R. D. T., de Freitas, Â. A., de Souza, M. M., Dias-Lopes, G., & Silva, R. C. M. C. (2026) · Applied Sciences · doi:10.3390/app16052461 · Cited by 1
Energetics of whole genome doubling and genomic instability
Beck, R. J., Tagal, V., Amin, S. B., Bakhoum, S. F., Maley, C. C., Verhaak, R. G. W., Gomes, A. P., & Andor, N. (2025) · Cancer Letters · doi:10.1016/j.canlet.2025.217878 · Cited by 3
Alanine catabolism as a targetable vulnerability for MYC-driven liver cancer
Montoya, T., Lee, J. V., Qiu, L., Krall, A., Matulionis, N., Seo, Y., Finck, B. N., Kelley, R. K., Christofk, H. R., & Goga, A. (2026) · Cell Reports · doi:10.1016/j.celrep.2026.117107 · Cited by 1
Self-citationAlderton, G. K. (2012) · Nature reviews. Cancer · doi:10.1038/nrc3234 · Cited by 1
Tracer-Based Cancer Metabolomic Analysis
Liu, J., Huang, J. L., & Xiao, G. G. (2021) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-51652-9_8 · Cited by 1
Computational modeling of metabolism in oncology
Fong, L. E., Jin, M., Kharbanda, S., Creixell, M., Wu, X., Zhang, D., Dubrot, J., Yates, K. B., Manguso, R. T., Kaufmann-Malaga, B., et al. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-15447-8.00005-2 · Cited by 1
War on Glioblastoma Multiforme: 2-Pronged Siege on Glutamine
Panchanathan, R. S., Sittur, M. G., Aoun, R. J. N., Pines, A. R., Swanson, K. R., & Bendok, B. R. (2016) · World Neurosurgery · doi:10.1016/j.wneu.2016.04.074 · Cited by 1
Metabolomic-Based Stratification in Prostate Cancer
Cacciatore, S., Zadra, G., & Loda, M. F. (2017) · Molecular pathology library · doi:10.1007/978-3-319-64096-9_15 · Cited by 1
Gougèlet, A., & Colnot, S. (2020) · médecine/sciences · doi:10.1051/medsci/2020051 · Cited by 1
Tsuge, M. (2021) · Viruses · doi:10.3390/v13101920 · Cited by 1
Wahl, D. R., & Venneti, S. (2017) · Springer eBooks · doi:10.1007/978-3-319-61401-4_6 · Cited by 1
Koltai, T., Reshkin, S. J., & Harguindey, S. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-819059-3.00002-2 · Cited by 1
Glutamine metabolism in liver cancer: role in progression and potential therapeutic targeting
Ratre, Y. K., Mehta, A., Sharma, R., Soni, V. K., Shukla, D., Tripathi, V. N., & Vishvakarma, N. K. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-98806-3.00025-8 · Cited by 1
Zhao, J., Zeng, X., & Hou, X. S. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/818575 · Cited by 1
Bioinformatics Software and Methods for Genome-wide Association and ChIP-Seq Studies.
Welch, R. (2013) · Deep Blue (University of Michigan)
Probing the anti-cancer mechanism of selenite : a metabolic approach.
Belshoff, A. C. (2013) · ThinkIR: The University of Louisville's Institutional Repository (University of Louisville) · doi:10.18297/etd/98
Preclinical Imaging in Oncology: Considerations and Recommendations for the Imaging Scientist
Bradley, D. P., & Wyant, T. L. (2013) · AAPS advances in the pharmaceutical sciences series · doi:10.1007/978-1-4614-8247-5_7
The Role of Glutamine Synthetase in the Glutamine Independence in Mammary Tissue
Kung, H., & Chi, J. (2014) · Springer eBooks · doi:10.1007/978-1-4939-1932-1_7
Targeting MYC and Exploring the Role of Mitochondrial Metabolism in Childhood Neuroblastoma
Zirath, H. (2014) · Figshare
Honorato, R. V. (2016) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.95.2016.tde-04012016-152835
Residual breast cancer metabolic phenotype after docetaxel treatment
Volpari, T. (2016) · University of Birmingham Institutional Research Archive (University of Birmingham)
Cellular Bioenergetics of Bone
Lee, W., & Long, F. (2018) · Primer on the metabolic bone diseases and disorders of mineral metabolism · doi:10.1002/9781119266594.ch129
Lin, Z. (2016) · ERA: Education and Research Archive (University of Alberta) · doi:10.7939/r3901zw84
Novel Applications of Machine Learning in Bioinformatics
Zhang, Y. (2019) · UKnowledge (University of Kentucky) · doi:10.13023/etd.2019.261
Magnetic Resonance Spectroscopy and Prognostic Analysis of Molecular Subtypes of Medulloblastoma
Zhang, Y., & Li, L. (2020) · Open Journal of Clinical Diagnostics · doi:10.4236/ojcd.2020.103007
Metabolic effects of oncogenic K-Ras in cancer cells
Bergner, R. (2018) · doi:10.25560/82596
The role of systemic metabolism in breast cancer progression
da Fonseca, C. S. R. D. S. G. (2015) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)
Uma visão estrutural sobre componentes do processo de adaptação metabólica de tumores
Ambrosio, A. L. B. (2018) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.76.2018.tde-25022021-104637
Sistem Pendidikan Tinggi Perlu Dinamik - Idris
Malaysia, U. (2008)
Fanale, D., Incorvaia, L., Russo, A. D., Longo, V. D., & Mirisola, M. G. (2021) · UNIPA Springer series · doi:10.1007/978-3-030-56051-5_25
Metadata
- Authors
- Yuneva, M. O., Fan, T. W. M., Allen, T. D., Higashi, R. M., Ferraris, D. V., Tsukamoto, T., Matés, J. M., Alonso, F. J., Wang, C., Seo, Y., Chen, X., & Bishop, J. M.
- Affiliations
- University of California, San Francisco (US)
- University of Louisville (US)
- Johns Hopkins University (US)
- Universidad de Málaga (ES)
- Corresponding author
- Yuneva, Mariia O.
- ORCID
- Venue
- Cell Metabolism
- Publisher
- Elsevier BV
- Published
- 2012-02
- Volume
- 15
- Issue
- 2
- Pages
- 157-170
- ISSN
- 1550-4131 (ISSN-L)
- PMC
- PMC3282107
- OpenAlex
- W2036659083
- Cited by
- 639
- References
- 64
- Citations by year
- 2026: 17 · 2025: 37 · 2024: 35 · 2023: 41 · 2022: 53 · 2021: 66 · 2020: 43 · 2019: 59 · 2018: 45 · 2017: 63 · 2016: 47 · 2015: 39 · 2014: 42 · 2013: 34 · 2012: 16
- FWCI
- 13.97
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Cell Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Cancer Institute (R35CA044338, R01CA118434)
- National Institute of Neurological Disorders and Stroke (R21NS074151)
- National Center for Research Resources (P20RR018733)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Amino Acid Enzymes and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Keywords
- cancer metabolism, c-Myc, MET, glutamine catabolism, glutamine synthetase, glutaminase, GLS1, GLS2, liver tumors, lung cancer, genetic lesions, glutamine accumulation
- MeSH terms
- Animals, Cell Transformation, Neoplastic, Citric Acid Cycle, Glucokinase, Glucose, Glutamine, Humans, Immunohistochemistry, Isotope Labeling, Liver Neoplasms, Experimental, Lung Neoplasms, Immunoblotting, Blotting, Western, Proto-Oncogene Proteins c-myc, DNA Primers, Lactic Acid, Proto-Oncogene Proteins c-met, Nuclear Magnetic Resonance, Biomolecular, RNA Interference, Cell Line, Tumor, Mice, Metabolome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
